2020 
Abi Nahed R, Reynaud D, Lemaitre N, Lartigue S, Roelants C, Vaiman D, Benharouga M, Cochet C, Filhol O and Alfaidy N
Protein kinase CK2 contributes to placental development: physiological and pathological implications.
Journal of Molecular Medicine, 2020,
98(1): 123-133
Frey B, Mika J, Jelonek K, Cruz-Garcia L, Roelants C, Testard I, Cherradi N, Lumniczky K, Polozov S, Napieralska A, Widlak P, Gaipl US, Badie C, Polanska J and Candéias SM Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy.
Strahlentherapie und Onkologie, 2020,
196(11): 1018-1033
Giroux P, Bhajun R, Segard S, Picquenot C, Charavay C, Desquilles L, Pinna G, Ginestier C, Denis J, Cherradi N and Guyon L
miRViz: A novel webserver application to visualize and interpret microRNA datasets.
Nucleic Acids Research, 2020,
48(W1): W252-W261
Oreglia M, Sbiera S, Fassnacht M, Guyon L, Denis J, Cristante J, Chabre O and Cherradi N
Early postoperative circulating miR-483-5p is a prognosis marker for adrenocortical cancer.
Cancers, 2020,
12(3): 724
Roelants C, Pillet C, Franquet Q, Sarrazin C, Peilleron N, Giacosa S, Guyon L, Fontanell A, Fiard G, Long JA, Descotes JL, Cochet C and Filhol O
Ex vivo treatment of tumor tissue slices as a predictive preclinical method to eEvaluate targeted therapies for patients with renal carcinoma.
Cancers, 2020,
12(1): 232
2019
Bakail M, Gaubert A, Andreani J, Moal G, Pinna G, Boyarchuk E, Gaillard MC, Courbeyrette R, Mann C, Thuret JY, Guichard, Murciano B, Richet N, Poitou A, Frederic C, Le Du MH, Agez M, Roelants C, BGurard-Levin Z, Almouzni G, Cherradi N, Guérois R and Ochsenbein F
Design on a rational basis of high-affinity peptides inhibiting the histone chaperone ASF1.
Cell Chemical Biology, 2019,
26(11): 1573-1585
Bestgen B, Kufareva I, Seetoh W, Abell C, Hartmann RW, Abagyan R, Le Borgne M, Filhol O, Cochet C, Lomberget T and Engel M 2-Aminothiazole derivatives as selective allosteric modulators of the protein kinase CK2. 2. Structure-based optimization and investigation of effects specific to the allosteric mode of action.
Journal of Medical Chemistry, 2019,
62(4): 1817-1836
Kufareva I, Bestgen B, Brear P, Prudent R, Laudet B, Moucadel V, Ettaoussi M, Sautel C, Krimm I, Engel M, Filhol O, Le Borgne M, Lomberget T, Cochet C and Abagyan R
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.
Scientific Reports, 2019,
9(1): 15893
Liang QX, Wang ZB, Lei WL, Lin F, Qiao JY, Filhol-Cochet O, Boldyreff B, Schatten H, Sun QY and Qian WPn
Deletion of Ck2β gene causes germ cell development arrest and azoospermia in male mice.
Cell Proliferation, 2019,
53(1):e12726
Rataj F, Planel S, Denis J, Roelants C, Filhol O, Guyon L, Feige JJ and Cherradi N Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis.
Oncogene, 2019,
38(26): 5174-5190
2018
Agosta C, Laugier J, Guyon L, Denis J, Bertherat J, Libé R, Boisson B, Sturm N, Feige JJ, Chabre O and Cherradi N
MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
International Journal of Cancer, 2018,
143(4): 944-57
Jardillier R, Chatelain F and Guyon L Bioinformatics methods to select prognostic biomarker genes from large scale datasets: A review.
Biotechnology Journal, 2018,
13(12): e1800103
Liang QX, Wang ZB, Lin F, Zhang CH, Sun HM, Zhou L, Zhou Q, Schatten H, Filhol-Cochet O, Brigitte B, Sun QY and Qian WP Ablation of beta subunit of protein kinase CK2 in mouse oocytes causes follicle atresia and premature ovarian failure.
Cell Death Disease, 2018,
9(5): 508
Picollet-D’hahan N, Tollance A, Belda Marin C, Liguori L, Marquette C, Filhol-Cochet O, Vilgrain I, Laffitte G, Rivera F, Alcaraz JP, Thélu J, Nicoud O, Moufle-Milot T, Legues M, Bouamrani A, Mombrun A, Gilquin B, Gerbaud S, Obeid P, Kermarrec F, Gidrol X and Martin DK 3D polyelectrolyte scaffolds to mimic exocrine glands: A step towards a prostate-on-chip platform.
The EuroBiotech Journal, 2018,
2(4): 180-195
Polena H, Creuzet J, Dufies M, Sidibé A, Khalil-Mgharbel A, Salomon A, Deroux A, Quesada JL, Roelants C, Filhol O, Cochet C, Blanc E, Ferlay-Segura C, Borchiellini D, Ferrero JM, Escudier B, Négrier S, Pages G and Vilgrain I The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: A marker of response to antitumoural treatment in metastatic renal cell carcinoma.
British Journal of Cancer, 2018,
118(9): 1179-1188
Roelants C, Giacosa S, Pillet C, Bussat R, Champelovier P, Bastien O, Guyon L, Arnoux V, Cochet C and Filhol O Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.
Oncotarget, 2018,
9(53): 30066-30078
2017
Abi Nahed R, Reynaud D, Traboulsi W, Ndagijimana S, Dieudonné MN, Hoffmann P, Benharouga M and Alfaidy N NLRP7 inflammasome is activated in FGR pregnancies: Physiological and physio-pathological implications.
Placenta, 2017,
57(Supplement C): 287
Bestgen B, Belaid-Choucair Z, Lomberget T, Le Borgne M, Filhol O and Cochet C In search of small molecule inhibitors targeting the flexible CK2 subunit interface.
Pharmaceuticals (Basel), 2017,
10(1): Article number 16
de Bourayne M, Gallais Y, El Ali Z, Rousseau P, Damiens MH, Cochet C, Filhol O, Chollet-Martin S, Pallardy M and Kerdine-Römer S Protein kinase CK2 controls T-cell polarization through dendritic cell activation in response to contact sensitizers.
Journal of Leukocyte Biology, 2017,
101(3): 703-715
Burute M, Prioux M, Blin G, Truchet S, Letort G, Tseng Q, Bessy T, Lowell S, Young J, Filhol O and Thery M Polarity reversal by centrosome repositioning primes cell scattering during epithelial-to-mesenchymal transition.
Developmental Cell, 2017,
40(2): 168-184
Desroches-Castan A, Feige JJ and Cherradi N ACTH action on messenger RNA stability mechanisms.
Frontiers in Endocrinology, 2017,
8: 3
Duchemin-Pelletier E, Baulard M, Spreux E, Prioux M, Burute M, Mograbi B, Guyon L, Théry M, Cochet C and Filhol O Stem cell-like properties of CK2β-down regulated mammary cells.
Cancers, 2017,
9(9): Article number 114
Leal-Egaña A, Letort G, Martiel JL, Christ A, Vignaud T, Roelants C, Filhol O and Théry M The size-speed-force relationship governs migratory cell response to tumorigenic factors.
Molecular Biology of the Cell, 2017,
28(12): 1612-1621
Lema I, Amazit L, Lamribet K, Fagart J, Blanchard A, Lombès M, Cherradi N and Viengchareun S RNA-binding protein HuR enhances mineralocorticoid signaling in renal KC3AC1 cells under hypotonicity.
Cellular and Molecular Life Scinces, 2017,
74(24): 4587-4597
Lema I, Amazit L, Lamribet K, Fagart J, Blanchard A, Lombès M, Cherradi N and Viengchareun S HuR-dependent editing of a new mineralocorticoid receptor splice variant reveals an osmoregulatory loop for sodium homeostasis.
Scientific Reports, 2017,
7: Article Number: 4835
2016
Burute M, Prioux M, Blin G, Truchet S, Letort G, Tseng Q, Bessy T, Lowell S, Young J, Filhol O and Théry M
Polarity reversal by centrosome repositioning primes cell scattering during Epithelial-to-Mesenchymal Transition.
Development Cell, 2016
Cherradi N microRNAs as potential biomarkers in adrenocortical cancer: Progress and challenges.
Frontiers in Endocrinology, 2016,
6: 195
de Bourayne M, Gallais Y, El Ali Z, Rousseau P, Damiens MH, Cochet C, Filhol O, Chollet-Martin S, Pallardy M and Kerdine-Römer S Protein kinase CK2 controls T-cell polarization through dendritic cell activation in response to contact sensitizers.
Journal of Leukocyte Biology, 2016
Rataj F, Planel S, Desroches-Castan A, Le Douce J, Lamribet K, Denis J, Feige JJ and Cherradi N The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-Binding Protein TIS11b/BRF1.
Molecular Biology of the Cell, 2016,
27(24): 3841-3854
2015
Engmann O, Giralt A, Gervasi N, Marion-Poll L, Gasmi L, Filhol O, Picciotto M, Gilligan D, Greengard P, Nairn A, Hervé D and Girault JA DARPP-32 interaction with adducin may mediate rapid environmental effects on striatal neurons.
Nature communications, 2015
Filhol O, Giacosa S, Wallez Y and Cochet C Protein kinase CK2 in breast cancer: The CK2β regulatory subunit takes center stage in epithelial plasticity.
Cellular and Molecular Life Sciences, 2015,
72(17): 3305-3322
| |
Roelants C, Giacosa S, Duchemin-Pelletier E, Mcleer-Florin A, Tisseyre C, Aubert C, Champelovier P, Boutonnat J, Descotes JL, Rambeaud JJ, Arnoux V, Long LA, Pasquier D, Laramas M, Kassem M, David-Boudet L, Schouttenten L, Bestgen B, Pillet C, Cochet C and Filhol O Dysregulated expression of protein kinase CK2 in renal cancer In
Protein kinase CK2 function in normal and disease states. Editors: Ahmed Khalil, Issinger Olaf-Georg, Szyszka Ryszard (Eds.), Springer, 2015, 12: pp 241-257 |
Ulges A, Klein M, Reuter S, Gerlitzki B, Hoffmann M, Grebe N, Staudt V, Stergiou N, Bohn T, Brühl TJ, Muth S, Yurugi H, Rajalingam K, Bellinghausen I, Tuettenberg A, Hahn S, Reißig S, Haben I, Zipp F, Waisman A, Probst HC, Beilhack A, Buchou T, Filhol-Cochet O, Boldyreff B, Breloer M, Jonuleit H, Schild H, Schmitt E and Bopp T Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses
in vivo.
Nature Immunology, 2015,
16(3): 267-275
Vilmont V, Filhol O, Hesse AM, Couté Y, Hue C, Rémy-Tourneur L, Mistou S, Cochet C and Chiocchia G Modulatory role of the anti-apoptotic protein kinase CK2 in the sub-cellular localization of Fas associated death domain protein (FADD).
Biochimica and Biophysica Acta, 2015,
1853(11 Pt A): 2885-2896
2014
Agosta C, Feige JJ, Bertherat J, Chabre O and Cherradi N MiR-483-5p and miR-139-5p promote invasion of adrenocortical carcinoma by targeting N-Myc Downstream-Regulated Gene family members.
Annales d'Endocrinologie, 2014,
75(5–6): 273-274
 | |
Biard D, Filhol O and Vandenbrouck Y
Tame the expression of the genes with DSIR.
Biofutur, 2014, (360): 52-55 |
Hien YE, Montersino A, Castets F, Leterrier C, Filhol O, Vacher H and Dargent B CK2 accumulation at the axon initial segment depends on sodium channel Nav1.
Febs Letters, 2014,
588(18): 3403-3408
de Thonel A, Hazoume A, Kochin V, Isoniemi K, Jego G, Fourmaux E, Hammann A, Mjahed H, Filhol O, Micheau O, Rocchi P, Mezger V, Eriksson JE, Rangnekar VM and Garrido C Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells.
Cell Death and Disease, 2014,
5: e1016
Viengchareun S, Lema I, Lamribet K, Keo V, Blanchard A, Cherradi N and Lombes M Hypertonicity compromises renal mineralocorticoid receptor signaling through Tis11b-mediated post-transcriptional control.
Journal of the American Society of Nephrology, 2014,
25(10): 2213-2221
2013
de Bourayne M, Ali ZE, Filhol O, Cochet C, Pallardy M and Kerdine-Römer S Protein kinase CK2 and JNK control Nrf2 activation in response to skin contact sensitizers in THP1 cells.
Toxicology Letters, 2013,
221(Supplement): S137
Chabre O, Libe R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ and Cherradi N Les microARN circulants miR-483-5p et miR-195 prédisent le risque de récidive et de décès des cancers cortico-surrénaliens.
Annales d'Endocrinologie, 2013,
74(4): 269
Chabre O, Libé R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ and Cherradi N Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.
Endocrine-Related Cancer, 2013,
20(4): 579-594
Ciais D, Cherradi N and Feige JJ Multiple functions of tristetraprolin/TIS11 RNA-binding proteins in the regulation of mRNA biogenesis and degradation.
Cellular and Molecular Life Sciences, 2013,
70(12): 2031-2044
Deshiere A, Duchemin-Pelletier E, Spreux E, Ciais D, Combes F, Vandenbrouck Y, Couté Y, Mikaelian I, Giusiano S, Charpin C, Cochet C and Filhol O Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction.
Oncogene, 2013,
32: 1373-1383
| |
Filhol O, Deshiere A and Cochet C Role of CK2 in the control of cell plasticity in breast carcinoma progression In
Protein kinase CK2 Edited by Pinna LA, Willey. Wiley-IUBMB Series on Biochemistry and Molecular Biology, 2013, pp 363-377 |
2012
Filhol O, Ciais D, Lajaunie C, Charbonnier P, Foveau N, Vert JP and Vandenbrouck Y DSIR: Assessing the design of highly potent siRNA by testing a set of cancer-relevant target genes.
PLoS One, 2012,
7(10): e48057
Prudent R, Vassal-Stermann E, Nguyen CH, Pillet C, Martinez A, Prunier C, Barette C, Soleilhac E, Filhol O, Beghin A, Valdameri G, Honore S, Aci-Seche S, Grierson D, Antonipillai J, Li R, Di Pietro A, Dumontet C, Braguer D, Florent JC, Knapp S, Bernard O and Lafanechere L Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth.
Cancer Research, 2012,
72(17): 4429-4439
Singh P, Soon PS, Feige JJ, Chabre O, Zhao JT, Cherradi N, Lalli E and Sidhu SB Dysregulation of microRNAs in adrenocortical tumors.
Molecular and Cellular Endocrinology, 2012,
351(1): 118-128
Tahtouh T, Elkins JM, Filippakopoulos P, Soundararajan M, Burgy G, Durieu E, Cochet C, Schmid RS, Lo DC, Delhommel F, Oberholzer AE, Pearl LH, Carreaux F, Bazureau JP, Knapp S and Meijer L Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.
Journal of Medicinal Chemistry, 2012,
55(21): 9312-9330
Tseng Q, Duchemin-Pelletier E, Deshiere A, Balland M, Guillou H, Filhol O and Thery M Spatial organization of the extracellular matrix regulates cell-cell junction positioning.
Proceedings of the National Academy of Sciences, 2012,
109(5): 1506-1511
2011
Chamboredon S, Ciais D, Desroches-Castan A, Savi P, Bono F, Feige JJ and Cherradi N Hypoxia-inducible factor-1α mRNA: A new target for destabilization by tristetraprolin in endothelial cells.
Molecular Biology of the Cell, 2011,
22(18): 3666-3678
Deshiere A, Duchemin-Pelletier E, Spreux E, Ciais D, Forcet C, Cochet C and Filhol O Regulation of epithelial to mesenchymal transition: CK2ß on stage.
Molecular and Cellular Biochemistry, 2011,
356(1-2): 11-20
Desroches-Castan A, Cherradi N, Feige JJ and Ciais D A novel function of Tis11b/BRF1 as a regulator of
Dll4 mRNA 3'-end processing.
Molecular Biology of the Cell, 2011,
22(19): 3625-3633
Filhol O and Cochet C Protein kinases curb cell death.
Science Signaling, 2011,
4(172): pe26
Giusiano S, Cochet C, Filhol O, Duchemin-Pelletier E, Secq V, Bonnier P, Carcopino X, Boubli L, Birnbaum D, Garcia S, Iovanna J and Charpin C Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarrays.
European Journal of Cancer, 2011,
47(5): 792-801
Moucadel V, Prudent R, Sautel CF, Teillet F, Barette C, Lafanechere L, Receveur-Brechot V and Cochet C Antitumoral activity of allosteric inhibitors of Protein kinase CK2.
Oncotarget, 2011,
2(12): 997-1010
Tseng Q, Wang I, Duchemin-Pelletier E, Azioune A, Carpi N, Gao J, Filhol O, Piel M, Thery M and Balland M A new micropatterning method of soft substrates reveals that different tumorigenic signals can promote or reduce cell contraction levels.
Lab on a Chip, 2011,
11(13): 2231-2240
Ziercher L, Filhol O, Laudet B, Prudent R, Cochet C and Buchou T Structure-function analysis of the beta regulatory subunit of protein kinase CK2 by targeting embryonic stem cell.
Molecular and Cellular Biochemistry, 2011,
356(1-2): 75-81
2010
Assie G, Louiset E, Sturm N, Rene-Corail F, Groussin L, Bertherat J, Thomas M, Lefebvre H, Feige JJ, Clauser E, Chabre O and Cherradi N Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal cushing's syndrome.
Journal of Clinical Endocrinology and Metabolism, 2010,
95(10): E253-262 | | |
Huillard E, Ziercher L, Blond O, Wong M, Deloulme JC, Souchelnytskyi S, Baudier J, Cochet C and Buchou T Disruption of CK2ß in embryonic neural stem cells compromises proliferation and oligodendrogenesis in the mouse telencephalon.
Molecular and Cellular Biology, 2010,
30(11): 2737-2749
Lopez-Ramos M, Prudent R, Moucadel V, Sautel CF, Barette C, Lafanechere L, Mouawad L, Grierson D, Schmidt F, Florent JC, Filippakopoulos P, Bullock AN, Knapp S, Reiser JB and Cochet C New potent dual inhibitors of CK2 and Pim kinases: Discovery and structural insights.
FASEB Journal, 2010,
24(9): 3171-3185
Planel S, Salomon A, Jalinot P, Feige JJ and Cherradi N A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1.
Oncogene, 2010,
29(45): 5989-6003
Prudent R, Moucadel V, Nguyen CH, Barette C, Schmidt F, Florent JC, Lafanechere L, Sautel CF, Duchemin-Pelletier E, Spreux E, Filhol O, Reiser JB and Cochet C Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2.
Cancer Research, 2010,
70(23): 9865-9874
Prudent R, Sautel CF and Cochet C Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2.
Biochimica et Biophysica Acta - Proteins and Proteomics, 2010,
1804(3): 493-498
Prudent R, Sautel CF, Moucadel V, Laudet B, Filhol O, Cochet C and Conn PM
In vitro and
in vivo assays of protein kinase CK2 activity.
Methods in Enzymology, 2010,
485: 597-610
Tseng Q, Deshieres A, Guillou H, Filhol-Cochet O and Thery M Regulation of mechanical equilibrium in multicellular arrangements.
Biophysical Journal, 2010,
98(3, Supplement 1): 211a-211a
2009
Chabre O, Mazzuco T, Feige JJ and Thomas M Tumorigenèse corticosurrénalienne et expression illégitime de récepteurs couplés aux protéines G : application d'un modèle animal à une pathologie humaine.
Médecine Clinique endocrinologie et diabète, 2009,
Avril 2009: 27-33
Duan H, Cherradi N, Feige JJ and Jefcoate C cAMP stimulation of the zinc finger protein ZFP36L1/TIS11b post-transcriptionally regulates expression and activity of the steroidogenic acute regulatory (STAR) protein.
Molecular Endocrinology, 2009,
23(4): 497-509
Filhol O and Cochet C Cellular functions of Protein kinase CK2: A dynamic affair.
Cellular and Molecular Life Science, 2009,
66(11-12): 1830-1839
Holland Z, Prudent R, Reiser JB, Cochet C and Doerig C Functional analysis of protein kinase CK2 of the human malaria parasite
Plasmodium falciparum.
Eukaryotic Cell, 2009,
8(3): 388-397
| |
Mazzuco TL, Chabre O, Feige JJ and Thomas M Luteinizing hormone receptor expression in human adrenal glands. In:
Gonadal and non-gonadal actions of gonadotropins. A Kumar, CV Rao, PK Chaturvedi, A Halder and N Rahman (eds), Narosa Publishing House, India, 2009, pp 87-97 |
Prudent R and Cochet C New protein kinase CK2 inhibitors: Jumping out of the catalytic box.
Chemistry and Biology, 2009,
16(2): 112-120
Viengchareun S, Kamenicky P, Teixeira M, Butlen D, Meduri G, Blanchard-Gutton N, Kurschat C, Lanel A, Martinerie L, Sztal-Mazer S, Blot-Chabaud M, Ferrary E, Cherradi N and Lombes M Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line.
Molecular Endocrinology, 2009,
23(12): 1948-1962
2008
Deshiere A, Ciais D, Cochet C and Filhol O Epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of Protein-kinase CK2.
Bulletin du Cancer, 2008,
95: S83-S83
Deshiere A, Theis-Febvre N, Martel V, Cochet C and Filhol O Protein kinase CK2 and cell polarity.
Molecular and Cellular Biochemistry, 2008,
316(1-2): 107-113
Laudet B, Moucadel V, Prudent R, Filhol O, Wong YS, Royer D and Cochet C Identification of chemical inhibitors of protein-kinase CK2 subunit interaction.
Molecular and Cellular Biochemistry, 2008,
316(1-2): 63-69
Lemmens L, Urbach S, Prudent R, Cochet C, Baldacci G and Hughes P Phosphorylation of the C subunit (p66) of human DNA polymerase δ.
Biochemical and Biophysical Research Communications, 2008,
367(2): 264-270
Prudent R, Hasenknopf B and Cochet C A new class of inorganic CK2 inhibitors.
Medecine Sciences (Paris), 2008,
24(12): 1012-1014
Prudent R, Moucadel V, Laudet B and Cochet C Novel potent and selective inhibitors of protein kinase CK2.
Bulletin du Cancer, 2008,
95: S66-S66
Prudent R, López-Ramos M, Moucadel V, Barette C, Grierson D, Mouawad L, Florent JC, Lafanechère L, Schmidt F and Cochet C Salicylaldehyde derivatives as new protein ikinase CK2 inhibitors.
Biochimica et Biophysica Acta (BBA) - General Subjects, 2008,
1780(12): 1412-1420
| |
Prudent R, Moucadel V, Laudet B, Barette C, Lafanechère L, Hasenknopf B, Li J, Bareyt S, Lacôte E, Thorimbert S, Malacria M, Gouzerh P and Cochet C Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
Chemistry and Biology, 2008,
15(7): 683-692 |
Prudent R, Moucadel V, Lopez-Ramos M, Aci S, Laudet B, Mouawad L, Barette C, Einhorn J, Einhorn C, Denis JN, Bisson G, Schmidt F, Roy S, Lafanechere L, Florent JC and Cochet C Expanding the chemical diversity of CK2 inhibitors.
Molecular and Cellular Biochemistry, 2008,
316(1-2): 71-85
Stipanovich A, Valjent E, Matamales M, Nishi A, Ahn JH, Maroteaux M, Bertran-Gonzalez J, Brami-Cherrier K, Enslen H, Corbille AG, Filhol O, Nairn AC, Greengard P, Herve D and Girault JA A phosphatase cascade by which rewarding stimuli control nucleosomal response.
Nature, 2008,
453(7197): 879-884
2007
Assrir N, Filhol O, Galisson F and Lipinski M
HIRIP3 is a nuclear phosphoprotein interacting with and phosphorylated by the serine-threonine kinase CK2.
Biological Chemistry, 2007,
388(4): 391-398
Cherradi N, Thomas M, Ciais D, Keramidas M and Feige JJ Hormonal regulation of VEGF expression and microvascularization In Angiogenesis in endocrine tissues, Edited by Vilgrain I and Feige JJ, Research Signpost, 2007, pp 121-129
Laramas M, Pasquier D, Filhol O, Ringeisen F, Descotes JL and Cochet C Nuclear localization of protein kinase CK2 catalytic subunit (CK2α) is associated with poor prognostic factors in human prostate cancer.
European Journal of Cancer, 2007,
43(5): 928-934
Laudet B, Barette C, Dulery V, Renaudet O, Dumy P, Metz A, Prudent R, Deshiere A, Dideberg O, Filhol O and Cochet C Structure-based design of small peptide inhibitors of protein-kinase CK2 subunit interaction.
Biochemical Journal, 2007,
408(3): 363-373
Laudet B, Prudent R, Filhol O and Cochet C Therapeutic agents targeting protein-protein interactions: Myth or reality?
Medecine Sciences (Paris), 2007,
23(3): 273-278
Mazzuco TL, Chabre O, Feige JJ and Thomas M Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis.
Molecular and Cellular Endocrinology, 2007,
265-266C: 23-28
Mazzuco TL, Thomas M, Martinie M, Cherradi N, Sturm N, Feige JJ and Chabre O Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome.
Arquivos Brasileiros de Endocrinologia & Metabologia, 2007,
51(9): 1452-1462
Medina-Palazon C, Gruffat H, Mure F, Filhol O, Vingtdeux-Didier V, Drobecq H, Cochet C, Sergeant N, Sergeant A and Manet E Protein Kinase CK2 phosphorylation of EB2 regulates its function in the production of EBV infectious viral particles.
Journal of Virology, 2007,
81(21): 11850-11860
2006
Cherradi N, Lejczak C, Desroches-Castan A and Feige JJ Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin.
Molecular Endocrinology, 2006,
20(4): 916-930
Laudet B, Prudent R, Dideberg O, Filhol O and Cochet C Développement d'un nouvel inhibiteur de la protéine kinase CK2 : un peptide synthétique dérivé de l'interface entre ses deux sous-unités.
Bulletin du Cancer, 2006,
93: S74-75
Laramas M, Pasquier D, Filhol O, Ringeisen F, Descotes JL and Cochet C Étude immunohistologique de l'expression et de la localisation subcellulaire de la CK2 sur 131 biopsies d'adénocarcinome de prostate : corrélation à des facteurs de mauvais pronostic.
Bulletin du Cancer, 2006,
93: S131
Martel V, Filhol O, Colas P and Cochet C p53-dependent inhibition of mammalian cell survival by a genetically selected peptide aptamer that targets the regulatory subunit of protein kinase CK2.
Oncogene, 2006,
25(56): 7343-7353
Mazzuco TL, Chabre O, Feige JJ and Thomas M Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features.
Journal of Clinical Endocrinology and Metabolism, 2006,
91(1): 196-203
Mazzuco TL, Chabre O, Sturm N, Feige JJ and Thomas M Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model.
Endocrinology, 2006,
147(2): 782-790
2005
Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X and Gimenez-Roqueplo AP Genetic testing in pheochromocytoma or functional paraganglioma.
Journal of Clinical Oncology, 2005,
23(34): 8812-8818
Blond O, Jensen HH, Buchou T, Cochet C, Issinger OG and Boldyreff B Knocking out the regulatory beta subunit of protein kinase CK2 in mice: Gene dosage effects in ES cells and embryos.
Molecular and Cellular Biochemistry, 2005,
274(1-2): 31-37
de Fraipont F, El Atifi M, Cherradi N, Le Moigne G, Defaye G, Houlgatte R, Bertherat J, Bertagna X, Plouin PF, Baudin E, Berger F, Gicquel C, Chabre O and Feige JJ Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy.
Journal of Clinical Endocrinology and Metabolism, 2005,
90(3): 1819-1829
Dubois C, Jankowski A, Gay-Jeune C, Chabre O, Pasquier D and Ferretti G Imaging of adrenal ganglioneuroma: a case report.
Journal of Radiology, 2005,
86(6 Pt 1): 659-662
Schaack B, Reboud J, Combe S, Fouqué B, Berger F, Boccard S, Filhol-Cochet O and Chatelain F A "DropChip" cell array for DNA and siRNA transfection combined with drug screening.
NanoBiotechnology, 2005,
1: 166-194
Theis-Febvre N, Martel V, Laudet B, Souchier C, Grunwald D, Cochet C and Filhol O
Highlighting protein kinase CK2 movement in living cells.
Molecular and Cellular Biochemistry, 2005,
274(1-2): 15-22